Moderately bullish activity in Pfizer (PFE), with shares up 2c, or 0.1%, near $25.82. Options volume relatively light with 84k contracts traded and calls leading puts for a put/call ratio of 0.3, compared to a typical level near 0.44. Implied volatility (IV30) is higher by 0.0 points near 22.97,and below the 52wk median, suggesting an expected daily move of $0.37. Put-call skew steepened, indicating increased demand for downside protection.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer price target lowered to $28 from $32 at Morgan Stanley
- Ideaya Biosciences completes enrollment in OptimUM-02 trial
- Pfizer announces results from HER2CLIMB-05 trial
- Pfizer price target raised to $29 from $28 at HSBC
- Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk